We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
N4 Pharma Plc | LSE:N4P | London | Ordinary Share | GB00BYW8QM32 | ORD 0.4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.025 | -3.03% | 0.80 | 0.75 | 0.85 | 0.825 | 0.80 | 0.83 | 501,502 | 10:33:59 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Drug & Proprietary Stores | 0 | -1.03M | -0.0057 | -1.44 | 1.48M |
Date | Subject | Author | Discuss |
---|---|---|---|
10/7/2018 18:23 | >> donk I was berated by hugh for giving that view so be careful😂! Also Nuvec although having potential, is not as far forward as some think. I repeat hugh is in denial... | nobbygnome | |
10/7/2018 18:20 | dplewis1, you really should try reading my posts rather than listening to that deluded voice in your head. From receiving the RNS whilst getting petrol I knew that the BB`s would not be happy with the news. I had a straight choice of spending all day arguing with various BB`s OR I could take advantage of the trading opportunity. I chose the latter. Yesterday was a profitable day for me, arguing with you is a complete waste of my time. | hughwilson | |
10/7/2018 18:19 | Nobby, fair point, but I think I was suggesting something a bit more subtle! Hugh hasn't denied he sold and bought back so fair play to his close connection initiative. | donk7 | |
10/7/2018 18:17 | Is it really worth it to produce a Slidenafil dose that acts in 15 mins when a generic variation for half the price will act in 30 mins? Plus NT acknowledged that Futura Medical have a phase three for an almost instant acting gel. Management seem asleep at the wheel there though. I just think it's money down the drain with Sildenafil and it would be better spent on accelerating Nuvec or one of the other reformulations. | donk7 | |
10/7/2018 18:13 | >>donk I think that would be called insider trading... | nobbygnome | |
10/7/2018 18:11 | But what was the problem? That is the key thing to detrrmine if it can just be ‘tweaked’ | nobbygnome | |
10/7/2018 18:02 | dplewis1, Nobody expected that last news, including Nigel. Both the company and myself stated very clearly that the sildenafil may have to be tweaked or perhaps your twisted mind skipped over that part. Work will continue on sildenafil to get the reformulation right. | hughwilson | |
10/7/2018 17:43 | Ngnome - he's done alright though if he picked up on vibes when in touch with NT and sold and bought back. Not that NT would say anything but Hugh might have sensed a disappointment in his tone or some negative video phone body language haha. | donk7 | |
10/7/2018 17:40 | I see hugh is in denial. I have seen it so many times before in this situation. A bit sad; the phrase throwing good money after bad comes to mind! | nobbygnome | |
10/7/2018 17:33 | Do you think as the CEO of the company and a major shareholder he might actually be aware of that Hugh? And do you think he'd respond to your emails with anything other than a positive stance on sildenafil? After all you were fully under the impression that the trials they just completed were going to be a success. Maybe he can formulate a cure for gullibility while he's at it, I've found him a buyer already. | dplewis1 | |
10/7/2018 17:32 | Probably half-decent timing with the sales and buy-backs HughW but the Vox charts gal (Nic Duke) reckons 5.2p support but she's been wrong on this before. Can never get the timing right perfectly but can see this having its day in the sun again in fourth qtr but maybe a dip a bit more before then without news. Can't see it going to 5.2p though. If it did I would load up. Just hope no hiccups with Nuvec. Not keen on the viagra reformulation as time to onset isn't that much quicker than other generics that will be half the price of N4P's ... if it ever gets to market. Waste of funds imo. All about Nuvec and maybe one or two of the other reformulations for me. | donk7 | |
10/7/2018 17:22 | PS, I have impressed upon Nigel that if he wishes to see further warrant money coming in then he needs to get the share price up ASAP. | hughwilson | |
10/7/2018 17:15 | donk7, £1.3m cash at year end plus another £780,000 warrant cash in the coffers post year end. | hughwilson | |
10/7/2018 17:04 | You bought back in Hugh? Good for you matey. Nic Duke on Vox Markets says this could go to 5.2p as no support but then contradicts and says 8.6p About 700k on the coffers and will probably need to raise as 500k needed for Sildenafil, cash needed for Nuvac development and no warrants exercising cash coming in at these levels. | donk7 | |
10/7/2018 16:25 | Large buys going to the bell. | hughwilson | |
10/7/2018 15:59 | eiresorpio, I posted his response on twitter. I will not post it here. The gist of it is that sildenafil is not a write off. | hughwilson | |
10/7/2018 15:55 | And what did Nigel say? | eiresorpio | |
10/7/2018 15:54 | dplewis1, no I`m not as idiots like you don`t deserve to be informed. | hughwilson | |
10/7/2018 15:51 | Are you still here? Didn't do you any good last time did it you clown. | dplewis1 | |
10/7/2018 15:47 | dplewis1, Wrong again, I have been in communication with Nigel today. Have you? | hughwilson | |
10/7/2018 15:39 | I repeat my post from the 3rd. "Anyway enough, I will leave you to the tumbleweed ghost town that this BB has become" | hughwilson | |
10/7/2018 15:36 | And for those wondering where I was yesterday, I spent more time on the phone to my broker about share purchases and again today than I was prepared to spend arguing on a BB. | hughwilson |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions